Entrant ICD Solutions

Safer Management of Care

Manage high DFTs with the industry’s most flexible option, DeFT Response™ technology. The programming options are designed to optimize rescue therapy to meet each patient’s unique physiology and changing needs.

100% success in preserving a 10J safety margin with DeFT Response technology vs. 83% achievement of 10J safety margin in fixed-tilt group of patients with competitive devices²

Reduced Inappropriate Therapy

ShockGuard™ technology with DecisionTx™ programming is designed to reduce inappropriate therapy and minimize the need for programming adjustments at implant.

98.4% of patients did not receive inappropriate shocks at 1 year (CI: 97.2 -99.2, p<0.0001)³

References

1. Data on file. 60101422 Internal Validation Report. Total 2019 global high-voltage implants, all manufacturers, estimated to be 440,434 units (Source: Abbott Market Research).
2. Gabriels J, Budzikowski AS, Kassotis JT. Defibrillation waveform duration adjustment increases the proportion of acceptable defibrillation thresholds in patients implanted with single-coil defibrillation leads. Cardiology. 2013;124(2):71-75.
3. Veltmann C, Wöhrle A, Busch M, et al. Reduction of inappropriate shocks of ICDs with enhanced SVT discriminators. EUROPACE presentation; 2017.